Published in J Biol Chem on September 05, 1993
The functional network of ion channels in T lymphocytes. Immunol Rev (2009) 3.21
K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci (2004) 3.12
Molecular diversity and regulation of renal potassium channels. Physiol Rev (2005) 2.56
Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol (2001) 1.85
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovasc Res (2010) 1.57
Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol (1999) 1.55
K+ channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev (2008) 1.52
Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol (2003) 1.44
Expression and biophysical properties of Kv1 channels in supragranular neocortical pyramidal neurones. J Physiol (2005) 1.43
Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc Natl Acad Sci U S A (2004) 1.31
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases. Inflamm Allergy Drug Targets (2011) 1.15
Region-specific spike-frequency acceleration in layer 5 pyramidal neurons mediated by Kv1 subunits. J Neurosci (2008) 1.11
Comparison of modulation of Kv1.3 channel by two receptor tyrosine kinases in olfactory bulb neurons of rodents. Receptors Channels (2004) 1.07
Components of after-hyperpolarization in magnocellular neurones of the rat supraoptic nucleus in vitro. J Physiol (1998) 1.06
Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci U S A (1997) 1.06
A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom. Biochem J (1997) 1.05
Induction of a glibenclamide-sensitive K-current by modification of a delayed rectifier channel in rat portal vein in insulinoma cells. Br J Pharmacol (1993) 1.01
The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer. Front Physiol (2013) 1.00
The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression. Drug Dev Res (2011) 0.98
Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel. Biophys J (2004) 0.98
Postnatal development of A-type and Kv1- and Kv2-mediated potassium channel currents in neocortical pyramidal neurons. J Neurophysiol (2011) 0.97
Kv1 channels selectively prevent dendritic hyperexcitability in rat Purkinje cells. J Physiol (2005) 0.96
Characterization of voltage-gated potassium channels in human neural progenitor cells. PLoS One (2009) 0.96
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med (2012) 0.96
Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol (2012) 0.96
Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J Physiol (2010) 0.95
Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus. PLoS One (2009) 0.94
The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel. Br J Pharmacol (1999) 0.94
Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1. Protein Sci (1999) 0.94
Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J Biol Chem (2012) 0.93
Kv1.3 channels in postganglionic sympathetic neurons: expression, function, and modulation. Am J Physiol Regul Integr Comp Physiol (2008) 0.89
Participation of Kv1 channels in control of membrane excitability and burst generation in mesencephalic V neurons. J Neurophysiol (2009) 0.88
Characterization of Ca(2+)-activated 86Rb+ fluxes in rat C6 glioma cells: a system for identifying novel IKCa-channel toxins. Br J Pharmacol (1996) 0.88
Novel K(+)-channel-blocking toxins from the venom of the scorpion Centruroides limpidus limpidus Karsch. Biochem J (1994) 0.87
Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function. PLoS One (2011) 0.86
Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells. PLoS One (2013) 0.86
Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes. PLoS One (2013) 0.85
Immunomodulatory effects of the Tityus serrulatus venom on murine macrophage functions in vitro. Mediators Inflamm (2005) 0.85
Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors. Biochim Biophys Acta (2011) 0.85
Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway. Pflugers Arch (2014) 0.85
Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney. Am J Physiol Renal Physiol (2010) 0.85
A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism. Biochem J (1999) 0.84
Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release. Br J Pharmacol (2000) 0.82
Serum-induced changes in the physiology of mammalian retinal glial cells: role of lysophosphatidic acid. J Physiol (1998) 0.82
The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker. PLoS One (2012) 0.82
Biochemical and electrophysiological characterization of two sea anemone type 1 potassium toxins from a geographically distant population of Bunodosoma caissarum. Mar Drugs (2013) 0.82
Recombinant expression of margatoxin and agitoxin-2 in Pichia pastoris: an efficient method for production of KV1.3 channel blockers. PLoS One (2012) 0.81
Kv1 and Kir2 potassium channels are expressed in rat brain endothelial cells. Pflugers Arch (2007) 0.81
Mature and precursor brain-derived neurotrophic factor have individual roles in the mouse olfactory bulb. PLoS One (2012) 0.81
Binding modes of two scorpion toxins to the voltage-gated potassium channel kv1.3 revealed from molecular dynamics. Toxins (Basel) (2014) 0.81
Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells. Cell Death Dis (2015) 0.81
Kv1.3 channels regulate synaptic transmission in the nucleus of solitary tract. J Neurophysiol (2011) 0.80
Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch (2003) 0.80
Pharmacology of currents underlying the different firing patterns of spinal sensory neurons and interneurons identified in vivo using multivariate analysis. J Neurophysiol (2011) 0.79
Scorpions from Mexico: From Species Diversity to Venom Complexity. Toxins (Basel) (2015) 0.79
Effect of dexamethasone on voltage-gated K+ channels in Jurkat T-lymphocytes. Pflugers Arch (2003) 0.79
Scorpion toxins for the reversal of BoNT-induced paralysis. Bioorg Med Chem Lett (2013) 0.79
Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases. Toxins (Basel) (2015) 0.78
Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system. Br J Pharmacol (2003) 0.78
Toxic peptides and genes encoding toxin gamma of the Brazilian scorpions Tityus bahiensis and Tityus stigmurus. Biochem J (1996) 0.77
Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state? Br J Pharmacol (2009) 0.76
Components of action potential repolarization in cerebellar parallel fibres. J Physiol (2014) 0.76
Computational Studies of Venom Peptides Targeting Potassium Channels. Toxins (Basel) (2015) 0.76
Stimulation of glucose uptake in murine soleus muscle and adipocytes by 5-(4-phenoxybutoxy)psoralen (PAP-1) may be mediated by Kv1.5 rather than Kv1.3. PeerJ (2014) 0.76
The Gatekeepers in the Mouse Ophthalmic Artery: Endothelium-Dependent Mechanisms of Cholinergic Vasodilation. Sci Rep (2016) 0.75
Kv1 channels and neural processing in vestibular calyx afferents. Front Syst Neurosci (2015) 0.75
Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3. J Neurochem (2016) 0.75
Functional unit size of the charybdotoxin receptor in smooth muscle. Proc Natl Acad Sci U S A (1994) 0.75
Expression and function of a CP339,818-sensitive K⁺ current in a subpopulation of putative nociceptive neurons from adult mouse trigeminal ganglia. J Neurophysiol (2015) 0.75
Voltage-dependent potassium currents expressed in Xenopus laevis oocytes after injection of mRNA isolated from trophozoites of Giardia lamblia (strain Portland-1). Physiol Rep (2013) 0.75
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem (1990) 3.98
Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron (1995) 3.75
Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release. Neuron (1993) 3.07
A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci (1999) 2.71
Primary sequence and immunological characterization of beta-subunit of high conductance Ca(2+)-activated K+ channel from smooth muscle. J Biol Chem (1994) 2.62
High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J Bioenerg Biomembr (1996) 2.31
Missteps and masquerade in American medical academe: clinical anatomists call for action. Clin Anat (1999) 2.27
Characterization of and modulation by a beta-subunit of a human maxi KCa channel cloned from myometrium. Receptors Channels (1995) 2.24
Mechanism of lactose translocation in membrane vesicles from Escherichia coli. 1. Effect of pH on efflux, exchange, and counterflow. Biochemistry (1979) 2.07
An open-channel blocker interacts with adjacent turns of alpha-helices in the nicotinic acetylcholine receptor. Neuron (1990) 2.06
Functional expression of Drosophila para sodium channels. Modulation by the membrane protein TipE and toxin pharmacology. J Gen Physiol (1997) 1.99
Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A (1988) 1.92
Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem (1994) 1.89
Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel. Biophys J (1992) 1.86
Mechanism of lactose translocation in membrane vesicles from Escherichia coli. 2. Effect of imposed delata psi, delta pH, and Delta mu H+. Biochemistry (1979) 1.85
Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther (1989) 1.82
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Eur J Cancer (1999) 1.72
Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71
Use of toxins to study potassium channels. J Bioenerg Biomembr (1991) 1.70
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med (1993) 1.67
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A (1992) 1.65
Timing of events in normal swallowing: a videofluoroscopic study. Dysphagia (2000) 1.64
Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. J Clin Invest (1980) 1.64
Active transport in membrane vesicles from Escherichia coli: the electrochemical proton gradient alters the distribution of the lac carrier between two different kinetic states. Biochemistry (1980) 1.60
An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry (1993) 1.55
Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem (1994) 1.54
Oxidative regulation of large conductance calcium-activated potassium channels. J Gen Physiol (2001) 1.54
Acetylcholine raises excitability by inhibiting the fast transient potassium current in cultured hippocampal neurons. Proc Natl Acad Sci U S A (1986) 1.47
Purified reconstituted lac carrier protein from Escherichia coli is fully functional. Proc Natl Acad Sci U S A (1984) 1.40
Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry (1992) 1.40
Inhibition of Na+/Ca2+ exchange in membrane vesicle and papillary muscle preparations from guinea pig heart by analogs of amiloride. Proc Natl Acad Sci U S A (1984) 1.39
Mechanism of lactose translocation in proteoliposomes reconstituted with lac carrier protein purified from Escherichia coli. 1. Effect of pH and imposed membrane potential on efflux, exchange, and counterflow. Biochemistry (1983) 1.37
Charybdotoxin and its effects on potassium channels. Am J Physiol (1995) 1.35
Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology. J Biol Chem (1997) 1.35
Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. Biochemistry (1999) 1.34
Purification and properties of D-amino acid dehydrogenase, an inducible membrane-bound iron-sulfur flavoenzyme from Escherichia coli B. J Biol Chem (1980) 1.32
Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J Biol Chem (1988) 1.31
Effects of charybdotoxin and iberiotoxin on the spontaneous motility and tonus of different guinea pig smooth muscle tissues. J Pharmacol Exp Ther (1991) 1.31
Pharmacology of voltage-gated and calcium-activated potassium channels. Curr Opin Chem Biol (1999) 1.30
Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis (1995) 1.29
Mechanism of lactose translocation in proteoliposomes reconstituted with lac carrier protein purified from Escherichia coli. 2. Deuterium solvent isotope effects. Biochemistry (1983) 1.28
Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor. J Pharmacol Exp Ther (1990) 1.27
Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom. J Biol Chem (1988) 1.23
Two calcium currents in a smooth muscle cell line. Am J Physiol (1986) 1.21
Functional reconstitution of the large-conductance, calcium-activated potassium channel purified from bovine aortic smooth muscle. Biochemistry (1995) 1.20
Inhibition of Na+/Ca2+ exchange in pituitary plasma membrane vesicles by analogues of amiloride. Biochemistry (1985) 1.20
The beta subunit of the high-conductance calcium-activated potassium channel contributes to the high-affinity receptor for charybdotoxin. Proc Natl Acad Sci U S A (1997) 1.20
Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels. Biochemistry (1993) 1.17
Computer-assisted design of an implantable, intrathoracic artificial lung. Artif Organs (1994) 1.17
Characterization of a phosphorylated pentasaccharide isolated from Hansenula holstii NRRL Y-2448 phosphomannan. Biochemistry (1973) 1.16
Sequence analysis of the inversion region containing the pilin genes of Moraxella bovis. J Bacteriol (1990) 1.15
Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom. J Biol Chem (1998) 1.15
Direct measurement of lactose/proton symport in Escherichia coli membrane vesicles: further evidence for the involvement of histidine residue(s). Biochemistry (1982) 1.15
Covalent attachment of charybdotoxin to the beta-subunit of the high conductance Ca(2+)-activated K+ channel. Identification of the site of incorporation and implications for channel topology. J Biol Chem (1994) 1.14
Lactose-proton symport by purified lac carrier protein. Biochemistry (1982) 1.14
Characterization of the Na+/H+ antiporter of alkalophilic bacilli in vivo: delta psi-dependent 22Na+ efflux from whole cells. J Bacteriol (1983) 1.13
Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel. J Biol Chem (1991) 1.12
Characterization of tissue-expressed alpha subunits of the high conductance Ca(2+)-activated K+ channel. J Biol Chem (1995) 1.12
Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity. J Biol Chem (1990) 1.11
High-conductance calcium-activated potassium channels in rat brain: pharmacology, distribution, and subunit composition. Biochemistry (1999) 1.11
Hyoid movement during swallowing in older patients with dysphagia. Arch Otolaryngol Head Neck Surg (2001) 1.11
Specific labeling of the lac carrier protein in membrane vesicles of Escherichia coli by a photoaffinity reagent. Proc Natl Acad Sci U S A (1980) 1.10
Identification, cloning, and sequencing of piv, a new gene involved in inverting the pilin genes of Moraxella lacunata. J Bacteriol (1990) 1.10
A comment on recent teaching of human anatomy in the United States. Surg Radiol Anat (2000) 1.09
Differential development of two classes of acetylcholine receptors in Xenopus muscle in culture. Science (1984) 1.08
Pancreatic islet transplantation. Effects on the glomerular lesions of experimental diabetes in the rat. Diabetes (1974) 1.07
The beta subunit of the high conductance calcium-activated potassium channel. Identification of residues involved in charybdotoxin binding. J Biol Chem (1998) 1.06
Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction. J Biol Chem (1999) 1.05
Regulation of excitation-secretion coupling by thyrotropin-releasing hormone (TRH): evidence for TRH receptor-ion channel coupling in cultured pituitary cells. J Membr Biol (1983) 1.03
Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers. Proc Natl Acad Sci U S A (1986) 1.03